Eisai’s GI Disease Biz to Integrate with Ajinomoto Pharma

Eisai and Ajinomoto will integrate their gastrointestinal (GI) disease businesses in April next year, the companies said on October 15. Under their deal sealed on the same day, Eisai will spin off part of its GI disease business and integrate...read more